DK1838318T3 - Anvendelse af oxycodon til behandling af visceral smerte - Google Patents

Anvendelse af oxycodon til behandling af visceral smerte

Info

Publication number
DK1838318T3
DK1838318T3 DK06700652T DK06700652T DK1838318T3 DK 1838318 T3 DK1838318 T3 DK 1838318T3 DK 06700652 T DK06700652 T DK 06700652T DK 06700652 T DK06700652 T DK 06700652T DK 1838318 T3 DK1838318 T3 DK 1838318T3
Authority
DK
Denmark
Prior art keywords
oxycodone
treatment
visceral pain
visceral
pain
Prior art date
Application number
DK06700652T
Other languages
Danish (da)
English (en)
Inventor
Asbjorn Mohr Drewes
Lars Arendt Nielsen
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35871217&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1838318(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Application granted granted Critical
Publication of DK1838318T3 publication Critical patent/DK1838318T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
DK06700652T 2005-01-18 2006-01-17 Anvendelse af oxycodon til behandling af visceral smerte DK1838318T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US64549005P 2005-01-18 2005-01-18
PCT/EP2006/050252 WO2006077212A1 (en) 2005-01-18 2006-01-17 Use of oxycodone for treating visceral pain

Publications (1)

Publication Number Publication Date
DK1838318T3 true DK1838318T3 (da) 2010-01-04

Family

ID=35871217

Family Applications (2)

Application Number Title Priority Date Filing Date
DK06700652T DK1838318T3 (da) 2005-01-18 2006-01-17 Anvendelse af oxycodon til behandling af visceral smerte
DK200700207U DK200700207U3 (da) 2005-01-18 2007-07-24 Anvendelse af oxycodon til behandling af visceral smerte

Family Applications After (1)

Application Number Title Priority Date Filing Date
DK200700207U DK200700207U3 (da) 2005-01-18 2007-07-24 Anvendelse af oxycodon til behandling af visceral smerte

Country Status (32)

Country Link
US (2) US20080200493A1 (de)
EP (1) EP1838318B1 (de)
JP (1) JP5049139B2 (de)
KR (10) KR20120089710A (de)
CN (1) CN101106996B (de)
AP (1) AP2249A (de)
AR (1) AR052880A1 (de)
AT (2) ATE446092T1 (de)
AU (1) AU2006207498B2 (de)
BR (1) BRPI0606247A2 (de)
CA (1) CA2595043C (de)
CY (1) CY1109660T1 (de)
DE (2) DE202006019887U1 (de)
DK (2) DK1838318T3 (de)
EA (1) EA013544B1 (de)
ES (1) ES2333901T3 (de)
HK (1) HK1107933A1 (de)
HR (1) HRP20090679T1 (de)
IL (1) IL184530A (de)
ME (1) ME01066B (de)
MX (1) MX2007007207A (de)
MY (1) MY144471A (de)
NO (1) NO338968B1 (de)
NZ (1) NZ555852A (de)
PL (1) PL1838318T3 (de)
PT (1) PT1838318E (de)
RS (1) RS51069B (de)
SI (1) SI1838318T1 (de)
TW (1) TWI432196B (de)
UA (1) UA85471C2 (de)
WO (1) WO2006077212A1 (de)
ZA (1) ZA200705231B (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GEP20115333B (en) 2005-11-14 2011-11-25 Rinat Neuroscience Corp Antagonist antibodies directed against calcitonin generelated peptide and using same
WO2008148798A2 (en) 2007-06-04 2008-12-11 Egalet A/S Controlled release pharmaceutical compositions for prolonged effect
CN107296957A (zh) 2008-03-04 2017-10-27 梯瓦制药国际有限责任公司 治疗慢性疼痛的方法
EP2393484A1 (de) 2009-02-06 2011-12-14 Egalet Ltd. Gegen missbrauch durch alkoholeinnahme widerstandsfähige zusammensetzung mit unmittelbarer freisetzung
AU2010265213B2 (en) 2009-06-24 2012-08-23 Egalet Ltd. Controlled release formulations
ES2912569T3 (es) * 2009-08-28 2022-05-26 Teva Pharmaceuticals Int Gmbh Métodos para tratar el dolor visceral administrando anticuerpos antagonistas dirigidos contra el péptido relacionado con el gen de la calcitonina
WO2012162243A2 (en) 2011-05-20 2012-11-29 Alderbio Holdings Llc Anti-cgrp compositions and use thereof
WO2012162253A2 (en) 2011-05-20 2012-11-29 Alderbio Holdings Llc Use of anti-cgrp or anti-cgrp-r antibodies or antibody fragments to treat or prevent chronic and acute forms of diarrhea
CN108014334B (zh) 2011-05-20 2021-11-30 H.伦德贝克公司 抗cgrp抗体和抗体片段用于在有需要的受试者中预防或抑制畏光或厌光的用途
HRP20240159T1 (hr) 2014-03-21 2024-04-12 Teva Pharmaceuticals International Gmbh Antagonistička protutijela usmjerena protiv peptida povezanog s genom kalcitonina i postupci koji ih koriste
US10556945B2 (en) 2014-03-21 2020-02-11 Teva Pharmaceuticals International Gmbh Antagonist antibodies directed against calcitonin gene-related peptide and methods using same
SG10201913032TA (en) 2016-09-23 2020-02-27 Teva Pharmaceuticals Int Gmbh Treating refractory migraine
WO2020106735A1 (en) 2018-11-19 2020-05-28 Jazz Pharmaceuticals Ireland Limited Alcohol-resistant drug formulations
SG11202106766SA (en) 2019-01-08 2021-07-29 H Lundbeck As Acute treatment and rapid treatment of headache using anti-cgrp antibodies

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5656295A (en) * 1991-11-27 1997-08-12 Euro-Celtique, S.A. Controlled release oxycodone compositions
US5478577A (en) * 1993-11-23 1995-12-26 Euroceltique, S.A. Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level
US5968551A (en) * 1991-12-24 1999-10-19 Purdue Pharma L.P. Orally administrable opioid formulations having extended duration of effect
US5958459A (en) * 1991-12-24 1999-09-28 Purdue Pharma L.P. Opioid formulations having extended controlled released
IL110014A (en) * 1993-07-01 1999-11-30 Euro Celtique Sa Solid controlled-release oral dosage forms of opioid analgesics
US5965161A (en) * 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
CA2250187A1 (en) * 1996-03-25 1997-10-02 Eli Lilly And Company Composition comprising olanzapine and a drug useful in the treatment of pain for use in the treatment of pain
UA81224C2 (uk) * 2001-05-02 2007-12-25 Euro Celtic S A Дозована форма оксикодону та її застосування
US6992193B2 (en) * 2003-06-10 2006-01-31 Adolor Corporation Sulfonylamino phenylacetamide derivatives and methods of their use

Also Published As

Publication number Publication date
EP1838318A1 (de) 2007-10-03
CN101106996A (zh) 2008-01-16
EA013544B1 (ru) 2010-06-30
DE202006019887U1 (de) 2007-07-26
SI1838318T1 (sl) 2010-02-26
AP2249A (en) 2011-07-18
JP5049139B2 (ja) 2012-10-17
AP2007004057A0 (en) 2007-08-31
ES2333901T3 (es) 2010-03-02
TWI432196B (zh) 2014-04-01
ATE446092T1 (de) 2009-11-15
KR20140091782A (ko) 2014-07-22
US20150190393A1 (en) 2015-07-09
AT9895U1 (de) 2008-05-15
AR052880A1 (es) 2007-04-11
RS51069B (sr) 2010-10-31
AU2006207498B2 (en) 2009-11-19
IL184530A (en) 2015-01-29
EP1838318B1 (de) 2009-10-21
ZA200705231B (en) 2008-06-25
WO2006077212A1 (en) 2006-07-27
KR20200128451A (ko) 2020-11-12
NO338968B1 (no) 2016-11-07
NO20074174L (no) 2007-10-17
DE602006009899D1 (de) 2009-12-03
KR20220165797A (ko) 2022-12-15
PT1838318E (pt) 2009-12-15
ME01066B (me) 2012-10-20
MY144471A (en) 2011-09-30
KR20170021905A (ko) 2017-02-28
MX2007007207A (es) 2007-08-15
KR20190135557A (ko) 2019-12-06
EA200701541A1 (ru) 2008-02-28
DK200700207U1 (da) 2007-08-24
US20080200493A1 (en) 2008-08-21
HK1107933A1 (en) 2008-04-25
AU2006207498A1 (en) 2006-07-27
BRPI0606247A2 (pt) 2009-06-09
PL1838318T3 (pl) 2010-03-31
UA85471C2 (ru) 2009-01-26
KR20080106991A (ko) 2008-12-09
KR20120089710A (ko) 2012-08-13
US9271974B2 (en) 2016-03-01
CA2595043A1 (en) 2006-07-27
CA2595043C (en) 2013-11-19
NZ555852A (en) 2010-01-29
IL184530A0 (en) 2007-10-31
DK200700207U3 (da) 2007-09-28
KR20230170811A (ko) 2023-12-19
CY1109660T1 (el) 2014-08-13
KR20210131450A (ko) 2021-11-02
JP2008526927A (ja) 2008-07-24
CN101106996B (zh) 2013-10-23
HRP20090679T1 (hr) 2010-01-31
KR20070100368A (ko) 2007-10-10
TW200637554A (en) 2006-11-01

Similar Documents

Publication Publication Date Title
DK1838318T3 (da) Anvendelse af oxycodon til behandling af visceral smerte
DE602005027052D1 (de) Endoskopbehandlungssystem
DK2409728T3 (da) System til ultralydsbehandling af væv
SMAP200900085A (it) 3-imidazolil-indoli per il trattamento di malattieproliferative
DK1928438T3 (da) Anvendelse af ibudilast til behandling af stofafhængighed
DK3424932T3 (da) Bronophthalider til terapeutisk anvendelse
DK1863899T3 (da) Hudbehandlingspræparater
DK2117525T3 (da) Anvendelse af 1-phenyl-3-dimethylamino-propanforbindelser til behandling af neuropatismerte
DK3403657T3 (da) Anvendelse af oligouronater til behandling af slimhyperviskositet
DK1685834T3 (da) Anvendelse af pinolensyre til behandling af obesitet
CY2200156T2 (el) Επεξεργασια λυματων
NO20070251A (no) Brønnbehandling
EP1968591A4 (de) Behandlung von synucleinopathien
DE602005021084D1 (de) ENDOSKOPisches BEHANDLUNGSSYSTEM
DK3332789T3 (da) Cladribinkur til behandling af multipel sklerose
SI1890705T1 (sl) Uporaba 24-nor-UDCA za zdravljenje holestatskih bolezni jeter
IL192933A0 (en) Benzoisoindole derivatives for the treatment of pain
EP2007790A4 (de) Verbindungen und verfahren zur behandlung von schmerzen
DK2001499T3 (da) Anvendelse af TGS-6 til behandling af osteoporose
IL178907A0 (en) Use of sulglicotide for the treatment of mucositis
GB0602857D0 (en) The treatment of sialorrhoea
GB0412262D0 (en) Use of compounds for the treatment of pain
GB0500024D0 (en) The treatment of pre-term labour
GB0518003D0 (en) Treatment of hepatatis c
TJ20050863A (en) The way of narcotism treatment